Cyp3a5 Genotyping
CYP3A5 Genotyping is a pharmacogenetic testing method that identifies genetic polymorphisms in the CYP3A5 gene to predict interindividual variability in the metabolism of calcineurin inhibitors, thereby guiding personalized immunosuppressive therapy.
359
Publications
21.6K
Citations
2.2K
Authors
658
Institutions
Publications per year
2017–2026
66
359
The genetic determinants of the CYP3A5 polymorphism
Elisabeth Hustert, Michael Haberl, Oliver Burk et al. · Pharmacogenetics · 2001 · 670 citations
Paul B. Watkins, Steven Wrighton, Jeffrey L. Barnett et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2019 · 305 citations · Full text
1–5 of 359
2.2K
11
h-index
9
h-index
9
h-index
9
h-index
8
h-index
1–5 of 2.2K
658
Inserm
Paris, France
12 h-index
46 publications
4.3K citations
Erasmus MC
Rotterdam, The Netherlands
11 h-index
34 publications
4.3K citations
Indiana University – Purdue University Indianapolis
Indianapolis, United States
10 h-index
52 publications
7.3K citations

Karolinska University Hospital
Stockholm, Sweden
10 h-index
48 publications
3.7K citations

Karolinska Institutet
Stockholm, Sweden
10 h-index
51 publications
3.9K citations
Erasmus University Rotterdam
Rotterdam, The Netherlands
10 h-index
27 publications
3.7K citations

Akita University
Akita, Japan
10 h-index
86 publications
4.4K citations
University of Washington
Seattle, United States
9 h-index
34 publications
6.9K citations
1–8 of 658
CPT · 26 publications · 3.5K citations
23
h-index
30 publications · 1.3K citations
20
h-index
17 publications · 664 citations
17
h-index
BJCP · 12 publications · 568 citations
12
h-index
13 publications · 1K citations
12
h-index
1–5